Joseph Manhede
Principal Accounting OfficerMr. Joseph Manhede is Principal Accounting Officer of Rocket Pharmaceuticals, Inc. from July 8, 2026. He has served as the Company’s Associate Vice President, Corporate Controller since April 2026. Prior to Rocket, Mr. Manhede was the Vice President and Financial Controller for Outlook Therapeutics, a clinical-stage biopharmaceutical company, where he was responsible for leading accounting and finance functions, including financial reporting, SEC compliance, internal controls, budgeting, and strategic financial planning, as well as supporting financing transactions and corporate governance initiatives. Prior to his time at Outlook, Mr. Manhede held senior finance and accounting positions at Amneal Pharmaceuticals, Unilife Corporation, and Celator Pharmaceuticals, Inc., where he served as Corporate Controller and played a key role in financial reporting, IPO readiness, SOX compliance, and acquisition integration. He began his career at Deloitte, where he served as an Audit Manager. Mr. Manhede is a Certified Public Accountant (CPA) and holds a Master of Business Administration from Holy Family University.
Positions
- Company NameRocket Pharmaceuticals, Inc.Stock CodeRCKTPositionPrincipal Accounting OfficerColleagues
- GDGaurav D. ShahCEO & Director
- PMPeter M. FongIndependent Chairman of the Board
- MLMartin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer
- CSChristopher StevensChief Operating Officer
- JSJonathan SchwartzChief Science & Gene Therapy Officer
- CBCarsten BoessIndependent Director
- DPDavid P. SouthwellIndependent Director
- RTRoderick Tze Ian WongDirector
